Cell Therapy Approaches Moving Along the Pipeline
Beta cell replacement therapies for type 1 diabetes (T1D) have made significant advances in just the past 10 years. We now have insulin-producing beta cells, derived from stem cells, which makes a donor (needed to provide the beta cells) obsolete. We have seen that stem cell-derived precursors can—once implanted in humans—mature into beta cells and […]
Accelerating Our Mission and Becoming More Volunteer Powered
Our bold vision for the future outlines strategies to drive greater impact to unlock cures and drive research that improves the lives of people with type one diabetes (T1D).
Myth vs. Fact: COVID-19 Can Trigger Diabetes
It’s been around the news: COVID-19 might trigger diabetes, at least in some people. That’s what several Breakthrough T1D-funded scientists posit. But let’s look at the evidence.
Tandem Diabetes Care in the Real World
Two leaders from Tandem Diabetes Care share real-world outcomes from Tandem insulin pump users, other practical insights.
Just Doing Experiments? Well, Ones that May Have Life-Saving Potential
Smart insulin; what is that? It’s the type of insulin that Chandra Bhattacharya, Ph.D., has spent her Breakthrough T1D-funded postdoctoral fellowship—the time right after you receive your doctoral degree, but are not ready for primetime as an assistant professor, yet—to pursue. And she has a lot of shoes to fill. At the Massachusetts Institute of […]
Breakthrough T1D and Tandem Diabetes Care Partner to Help Educate, Support the T1D Community
New, national partnership will use Breakthrough T1D’s community-facing platforms to highlight benefits of devices such as insulin pumps, continuous glucose monitors and novel treatment approaches.
Nation’s Largest Insurer Expands Insulin Pump Coverage
In a victory for Breakthrough T1D’s Coverage2Control Campaign, people with T1D now have more choice in how they manage their diabetes.
Breakthrough T1D’s One Night: The Power of Us Is Unstoppable
One Night. One Community. One Purpose: to show the world the undeniable power of people living with T1D.
Tandem Control-IQ—Now Authorized For Children
Tandem Diabetes announced FDA clearance of an expanded pediatric indication for the Tandem t:slim X2™ insulin pump with Control-IQ™ technology in children ages six and older.
At ADA, Breakthrough T1D-Funded Research Takes Center Stage (featuring a “Happy Hour” with Dr. Aaron Kowalski)
At the American Diabetes Association’s Scientific Sessions, which was held virtually from June 12-16, scientists presented on some of the most important topics, from artificial pancreas trials to immune therapy trials to prevention trials, all with the same goal: ending type 1 diabetes (T1D) and improving lives until that day comes. Breakthrough T1D played the […]
